ISSUE #31
Apr 15, 2026
📚
Browse Past Issues
EDITOR'S NOTE
📌 Don't Forget!
The webinar
"
Winning Korean Bio/Healthcare Partnerships"
is happening this week.
If you’ve already registered, we look forward to seeing you there!
Registration Required
Free Webinar
April 15, 2026 | 5:00 PM (PDT)
April 16, 2026 | 9:00 AM (KST)
* Hosted by the U.S. Commercial Service at the U.S. Embassy in Korea.
Missed the registration?
Follow us on
LinkedIn
and visit our
website
to stay updated on upcoming events and opportunities.
🎉 A special event for our followers is coming as we approach 4K on LinkedIn!
⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄⠄
THIS WEEK:
K-Bio Overtakes Japan,
Secures Third in Global
Drug Pipelines
South Korea has risen to third place in the global share of new drug candidate substances (pipelines), following the United States and China.
Apr 9, 2026
· via
[ChosunBiz
]
South Korea’s Celltrion: Truxima
Tops U.S. Market,
Overtaking Rituxan in Oncology
Globally, the biotech industry is watching Celltrion’s ability to navigate U.S. trade policies.
Apr 9, 2026
· via
[GeneOnline
]
Chaebol
heirs double down on biotech in
new expansion wave
Executives across major groups are driving expansion into healthcare and biotech.
Apr 10, 2026
· via
[Pulse by Maeil Business Newspaper]
WHAT WE'VE BEEN UP TO
#Members
#Co-hosts
2026 1st CEO Golf Affinity ⛳ | Apr 9
Members-only networking program fostering collaboration among KoreaBIO member CEOs!
2026 H1 Follow-up Investment IR Program (Smart Start) 💼 | Apr 9
Connecting biotech startups with leading VCs and strategic investors for funding and collaboration opportunities!
▶ Notice
▶ Recent Events
▶ Latest News
Here's what's happening across Korea's bio industry!
INSIDE KOREA BIO
🚀Goes Global
∎ ABL Bio secures
US orphan status
for cholangiocarcinoma drug Torbeximig - ChosunBiz
∎ GC Biopharma secures
FDA approval
for the Laredo plasma center, completing clearance of all seven U.S. sites - THE BIO
∎ Yuhan’s Gaucher drug candidate wins
FDA orphan status
- The Korea Herald
∎ Rokit Healthcare Establishes
30 Billion Won Joint Venture
With UAE Investor - The Chosun Ilbo
∎ Korean
Stem Cell Therapies
Gain Global Traction via
Clinical Success
- The Chosun Ilbo
∎ Korea's Miracell receives
US FDA 510(k)
clearance for stem cell extraction system - BioSpectrum Asia
📈Growth & Performance
∎ 26 Pharma and Biotech Companies Post Over
KRW 100 Billion
in Sales and Double-Digit Operating Margins - Newsmp
∎ Celltrion’s
ADC
candidate CT-P71 wins
FDA Fast Track
in urothelial cancer - KBR
∎ Samsung BioLogics and Celltrion Get U.S.
Tariff Relief
- Business Korea
∎ JW Pharmaceutical signs $81 mil. license-in
deal with China's
Gan & Lee for
GLP-1 obesity drug
- KBR
💡Innovation & Trends
∎ Gyeonggi Economic Science Agency to
Train 500 Bio Professionals
- Seoul Economic Daily
∎ Noul takes
AI blood analysis
into regenerative medicine with US partner - KBR
∎ Dongwon Industries pursues
tuna-based bio
push in South Korea - ChosunBiz
∎ The Next Chapter of Andong Agriculture:
Smart Farms
Lead the Way - The Asia Business Daily
∎ Korea’s AI Healthcare Is Advancing, but Hospitals
Struggle to Use
It at Scale - KoreaTechDesk
WHAT'S COMING UP?
For Companies Interested in the North American Market
(Korean Companies Only)
Canada Bio-Industry Visit Program
@BIO 2026
New
June 17-19, 2026
Explore the U.S. Biotech Ecosystem in San Diego!
(Korean Companies Only)
On-site Tour Program
@BIO 2026
New
June 26, 2026
Advance Your Biotech BD Skills!
(Conducted in Korean)
2026 Dealmaker Academy 2nd Seminar
May 15, 2026
📰
Join our press list
Get KoreaBIO updates
& media resources
💬
Share Your thoughts!
How was your letter today?
✉️
Korean Newsletter
Daily biotech news from Korea and around the world
— in Korean
Stay connected with
everything
KoreaBIO
Watch and Join!
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
+82-31-628-0037
수신거부
Unsubscribe
